Alzheimer's disease currently lacks a definitive cure, but several treatments aim to manage symptoms and slow progression. Medications such as cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine are commonly prescribed to improve cognitive function and manage behavioral symptoms. Non-pharmacological approaches like cognitive stimulation therapy and structured routines can also help maintain quality of life. Lifestyle adjustments such as regular physical exercise, a balanced diet, and social engagement are advocated to support brain health. Research into new therapies, including immunotherapies and gene therapies, offers hope for future treatments. Careful management involving healthcare professionals, caregivers, and support networks remains crucial in providing comprehensive care for individuals affected by Alzheimer's disease and related dementias.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States